Research Papers: PDF OnlyGable P S; Le, D T; McGehee, W; Rapaport, S IBlood Coagulation & Fibrinolysis: September 1997 - p 327-335 Buy Abstract We have standardized a simple screening test for abnormalities of the protein C anticoagulant system. The test is basically a modified prothrombin time in which one aliquot of a test plasma is incubated for 3 min at 37°C with Protac® and another is incubated with buffer. During the incubation the Protac® activates both protein C and factor V. The plasmas are then clotted with thromboplastin plus Ca2+, and the clotting time difference reflects the ability of the activated protein C (APC) to inactivate factor Va. With the use of Thromboplastin C Plus as the activator, clotting time differences found in 31 normal subjects (10.4 ± 3.5 s, mean ± 2SD) were distinct from clotting time differences found in 57 of 58 subjects with established APC-resistant factor Va (3.6 ± 3.0 s). In addition, the Protac® -based test detected six of seven patients with isolated protein C deficiency and 20 of 28 patients with isolated protein S deficiency. Because of the reported high prevalence of heterozygous APC-resistant factor Va in Caucasian populations, it should be particularly useful in determining whether this genetic risk is present in individuals who have experienced or are at increased environmental risk of venous thrombosis. © Lippincott-Raven Publishers.